In past years, a number of studies focused on the investigation of the effects due to PHGDH inhibition, especially on the metabolism of cancer cells related to decreased L-Ser levels (Pacold et al., 2016; Gao et al., 2018; Reid et al., 2018). The gene discussed is PHGDH; the disease is cancer.